Day-1 launches don't fail on the science.
They fail in the White Space.

Fractional supply chain leadership for emerging biopharmas heading into launch. We orchestrate your CDMO, CPO, 3PL, and internal team as one accountable engine — embedded or interim.

Book Your Pressure-Test 60 min · No deck · No obligation

No juniors. The principal who engages is the principal who delivers.

30+ launches · Virtual Manufacturer model · Rare disease & specialty biologics

For CEOs, COOs, and Heads of Technical Operations at emerging biopharma

30+
Commercial launches supported across rare disease and specialty biologics.
Experience across large pharma, emerging biotech, and virtual manufacturer models.
End-to-end operating models built and stabilized under regulatory and commercial pressure.

Transition from Development to Commercial Execution

We help biopharma companies transition from late-stage development to commercial execution with supply chains built to deliver on Day 1—or designed to preserve strategic flexibility when timelines shift.

With 20+ years across large pharma, emerging biotech, and advisory roles, we specialize in building and stabilizing operating models at inflection points: pre-approval readiness, first commercial launch preparation, external manufacturing scale-up, and operational transformation under regulatory and commercial pressure.

The Integration Layer

Emerging biotechs have deep science but rarely have commercial supply chain leadership on staff before Phase III. Critical decisions are routinely deferred to CDMOs with misaligned incentives. The handoffs, decisions, and risk between nodes—what we call the White Space—belongs to no one. That's where we operate.

Phase-Appropriate Leadership

Big Pharma talent brings Big Pharma overhead. We deliver precise, phase-appropriate leadership—whether as your interim Head of Supply Chain or embedded alongside your existing executives.

Flexible Execution Models

We lead engagements personally and structure our role to match your context—from fully owning the mandate to embedding within your existing leadership team.

Interim Head of Supply Chain

We step in as your acting Head of Supply Chain, owning the mandate end-to-end from late-stage development through launch and early commercial steady state. We lead internal teams and external partners, run governance, and build the operating model you will ultimately hand to a permanent hire.

Embedded Operator / Advisor

We work alongside your COO, Head of Technical Operations, or existing supply leader to design and run the model, filling critical gaps without displacing internal leadership. We co-own critical path decisions, orchestrate partners, and build the execution infrastructure behind repeatable performance.

Hybrid Model

We take direct ownership of high-stakes workstreams—such as 3PL integration, external manufacturing scale-up, or S&OP—while mentoring internal leaders who will ultimately own the function. The goal is a clean transition from external support to sustainable in-house capability.

Your Partners Execute. We Orchestrate the Whole.

Each partner in your network optimizes for their own scope. We supply the layer above them: a single governance rhythm, decision cadence, and risk view that turns five vendors into one accountable supply chain. Our Commercial Orchestration Engine is human leadership—not a software platform—and it's the difference between a launch you hope for and a launch you can defend.

Dependency Management

Map and sequence every cross-partner dependency — from API batch release to packaging component procurement — so nothing falls between the cracks.

Decision Cadence & Escalation

Establish clear decision rights, regular governance forums, and escalation paths so issues surface early and get resolved before they cascade.

Integrated Risk Management

Maintain a living risk register across the network. Quantify impact, assign owners, track mitigations — not just at each node, but across the full value chain.

Data & Information Flow

Define what data flows between partners and when — batch records, CoAs, demand signals, inventory positions — so decisions are based on facts, not assumptions.

Accountability Without Ambiguity

Clarify who owns what — at the sponsor, at each partner, and in the integration layer — so accountability is explicit and nothing is "someone else's problem."

A Planning Backbone That Fits Your Stage

Most emerging biotechs plan their supply chain in spreadsheets — until the first stockout or batch expiry forces a scramble.

We design and run your S&OP and supply planning backbone with the right tool for your stage — from disciplined, advanced Excel models to lightweight planning tools to specialty third-party SaaS platforms built for pharma. We're tool-agnostic: we select for your network, team, and runway, implement it, and embed it into your decision-making cadence.

Whatever the tool, it becomes the operational backbone for launch orchestration—feeding your governance forums, risk register, and partner scorecards from a single source of truth.

Select
Match the tool to the stage — a disciplined Excel model, a lightweight planning tool, or a specialty pharma SaaS platform. The right answer depends on your network, team, and runway, not on anyone's license revenue.
Implement
Stand up product hierarchy, BOM structure, supplier lead times, and safety stock policy — then wire it into your governance cadence so weekly forums, gate reviews, and S&OP cycles pull from a single source of truth.
Transfer
Train your team to own the model or platform independently. When we step back, you keep the capability — not a dependency on us.

The Golden Thread: Critical Path

Every launch has a single constraining path. Miss one upstream link and it cascades through the entire network.

T-18M to Launch
T-18M
T-12M
T-9M
T-6M
T-3M
Launch
Drug Substance
DS PPQ & Registration Batches
Drug Product
DP Mfg & Batch Release
Tech Transfer / PPQ
Packaging & Serialization
Commercial Pkg & Serialization
Label & Artwork Readiness
Distribution & Trade
FG to 3PL · Channel Stocking
3PL Integration & State Licensing

The Golden Thread runs from the regulatory label through Day-1 stocking — drug substance to drug product to packaging and serialization to distribution. A slip in any upstream link cascades through every node downstream. We map and pressure-test every handoff on this path before it can cost you the date.

The Integration Between Nodes

We govern the White Space across the four nodes of the Virtual Manufacturer model: drug substance, drug product, packaging and serialization, and distribution. Each handoff is a decision point with a named owner, a Golden Thread back to the regulatory label, and a single source of truth for status and risk. When something slips—and something always slips—we already know who needs to know what, by when.

Integration & Governance

  • Map and sequence every cross-partner dependency—from API batch release to packaging component procurement—so nothing falls between the cracks.
  • Establish clear decision rights, regular governance forums, and escalation paths so issues surface early and get resolved before they cascade.
  • Maintain a living risk register across the network, quantifying impact, assigning owners, and tracking mitigations across the full value chain.

Launch Critical Path

  • S&OP cadence, scenario modeling, and safety stock policy tailored to a single-product or focused portfolio launch.
  • Tech transfer governance, process validation, packaging line qualification, and regulatory-manufacturing alignment.
  • 3PL integration, cold chain lane qualification, state licensing, serialization readiness, and mock launch execution.

External Manufacturing & Network Design

  • CDMO, packager, and 3PL selection, including commercial and quality due diligence.
  • Contract negotiation, quality agreements, and capacity reservation aligned to your risk appetite and capital discipline.
  • Network strategies that preserve flexibility when timelines or forecast assumptions inevitably shift.

Digital Backbone & Execution Infrastructure

  • Right-sized digital enablement—supply planning from advanced Excel models to specialty pharma SaaS, dashboards, data flows, and governance tooling—without enterprise-scale overhead.
  • Set up product hierarchy, BOM structure, supplier lead times, and safety stock policies tailored to your specific network.
  • Wire the planning backbone into your governance cadence so weekly forums, monthly gate reviews, and S&OP cycles all pull from a single source of truth.

How We Run Launch Readiness

A structured operating rhythm with clear deliverables and defined decision rights — from week one.

01

0–30 Day Stand-Up

  • Map the critical path and all partner dependencies
  • Define decision rights and escalation thresholds
  • Surface top risks and assign mitigation owners
  • Establish governance cadence and reporting rhythm
02

Ongoing Cadence

  • Weekly orchestration forum across all partners
  • Monthly gate reviews with executive stakeholders
  • S&OP cycle integration as applicable
  • Issue tracking with closed-loop resolution
03

Core Deliverables

  • Integrated launch readiness plan
  • Living risk register with quantified impact
  • Decision log with rationale and owners
  • Partner scorecards and performance tracking

What We've Delivered

Representative outcomes from recent launch and supply chain engagements (anonymized for client confidentiality).

6 Weeks Early
Packaging Risk Averted
Situation: Child-resistant packaging requirement identified late — 8 months before target PDUFA.
Action: Mapped regulatory requirement to packaging validation timeline. Accelerated component sourcing with CPO partner.
Outcome: Compliant packaging validated 6 weeks before deadline. Zero delay to launch.
30% Less Cash Exposure
Capacity Secured
Situation: Demand forecast exceeded CDMO capacity reservation. No long-term supply agreement in place.
Action: Built scenario-driven safety stock policy. Negotiated long-term capacity commitment tied to demand triggers.
Outcome: Supply continuity secured for 18-month horizon. Cash exposure reduced by 30%.
4 Months Saved
Hidden Lead Time Avoided
Situation: State licensing and serialization readiness not on anyone's critical path. Discovered at T-6 months.
Action: Integrated licensing and serialization milestones into master launch plan. Stood up parallel workstreams with 3PL and legal.
Outcome: All licenses and serialization live before commercial readiness gate. Avoided 4-month delay.

Interventions for Critical Inflection Points

We typically engage at three critical inflection points in the path from development to commercial scale:

Trigger: First Launch

Typical role: Interim Head of Supply Chain or hybrid model

Embedded leadership from pre-launch build through commercial steady state. We orchestrate your entire supply chain until you are ready to hire permanently, then support a clean transition. We map and pressure-test every link on the critical path so Day-1 shipment is an operational decision, not a scramble.

Trigger: Slipping Timelines

Typical role: Embedded operator/advisor on critical workstreams

Targeted intervention for at-risk workstreams—such as 3PL integration, packaging validation, or serialization readiness—when timelines are in jeopardy and execution is mandatory. We work alongside your leadership team to stabilize the plan, recover schedule, and create a governance rhythm that prevents repeat crises.

Trigger: Post-Launch Growth

Typical role: Embedded advisor or hybrid model

Transition from launch-mode heroics to sustainable operations. We establish S&OP, optimize partner performance, and build internal capability for long-term independence so your operating model holds up under real-world demand, inspections, and capital scrutiny.

Led by Operators Who've Built This Before

We deliberately stay small. Every engagement is led personally by our principals—the same people in the room are the people doing the work, whether serving as interim leadership or embedded operators. No juniors. No ramp-up. The principals who engage are the people who deliver.

Brian Adams

Brian Adams

Managing Principal

20+ years building commercial supply chains for emerging biopharma, including roles at Daiichi Sankyo, Blueprint Medicines, and Cytokinetics. Has personally led packaging, serialization, and 3PL integration for multiple first-in-class launches, and built supply chain functions from zero through post-launch scale-up. MBA with hands-on operator experience across large pharma and virtual biotech models.

The Extended Bench

Senior Specialists, Engaged as Needed

Behind every engagement sits a trusted network of senior operators we've launched with before—quality and regulatory leads, serialization and artwork specialists, trade & distribution veterans, and planning-systems experts. They're brought in deliberately, under ISC leadership, only when the work calls for it. You always know exactly who is doing the work and why they're there.

No juniors. No ramp-up. The principals who engage are the people who deliver.

Get Started

Map your critical path

Confidential, 60-minute working session focused on your specific launch or supply chain inflection point. No obligation, no junior handoffs.

Schedule directly or request a session.

We respond within one business day.

Request a Critical Path Pressure-Test

Confidential. No obligation. We'll respond within one business day.